Scilex Holding Company (NASDAQ: SCLXW) Stock Competitors & Peer Comparison
See SCLXW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SCLXW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SCLXW | $0.03 | +0.00% | 7.6M | N/A | -$32.57 | N/A |
| LLY | $1,354.00 | -0.79% | 1.3T | 43.57 | $31.49 | +0.49% |
| JNJ | $276.22 | +1.43% | 664.8B | 25.74 | $10.73 | +1.92% |
| ABBV | $291.31 | +1.07% | 514.9B | 28.59 | $10.19 | +2.39% |
| MRK | $146.73 | -0.14% | 362B | 45.70 | $3.21 | +2.32% |
| NVS | $162.55 | +0.38% | 307B | 18.71 | $8.69 | +2.93% |
| AZN | $186.43 | -0.22% | 289.1B | 20.13 | $9.26 | +1.74% |
| AMGN | $460.42 | +0.03% | 248.8B | 20.57 | $22.37 | +2.16% |
| GILD | $166.89 | -0.41% | 206.9B | -427.74 | -$0.39 | +1.94% |
| NVO | $40.31 | +0.02% | 177.7B | 10.03 | $4.02 | +4.46% |
Stock Comparison
Eli Lilly and Company (NYSE: LLY)
SCLXW vs LLY Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, LLY has a market cap of 1.3T. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while LLY trades at $1,354.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas LLY's P/E ratio is 43.57. In terms of profitability, SCLXW's ROE is +1.90%, compared to LLY's ROE of +0.84%. Regarding short-term risk, SCLXW is more volatile compared to LLY. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check LLY's competition here
Johnson & Johnson (NYSE: JNJ)
SCLXW vs JNJ Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, JNJ has a market cap of 664.8B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while JNJ trades at $276.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas JNJ's P/E ratio is 25.74. In terms of profitability, SCLXW's ROE is +1.90%, compared to JNJ's ROE of +0.20%. Regarding short-term risk, SCLXW is more volatile compared to JNJ. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check JNJ's competition here
AbbVie Inc. (NYSE: ABBV)
SCLXW vs ABBV Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, ABBV has a market cap of 514.9B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while ABBV trades at $291.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas ABBV's P/E ratio is 28.59. In terms of profitability, SCLXW's ROE is +1.90%, compared to ABBV's ROE of -2.03%. Regarding short-term risk, SCLXW is more volatile compared to ABBV. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check ABBV's competition here
Merck & Co., Inc. (NYSE: MRK)
SCLXW vs MRK Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, MRK has a market cap of 362B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while MRK trades at $146.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas MRK's P/E ratio is 45.70. In terms of profitability, SCLXW's ROE is +1.90%, compared to MRK's ROE of +0.05%. Regarding short-term risk, SCLXW is more volatile compared to MRK. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check MRK's competition here
Novartis AG (NYSE: NVS)
SCLXW vs NVS Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, NVS has a market cap of 307B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while NVS trades at $162.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas NVS's P/E ratio is 18.71. In terms of profitability, SCLXW's ROE is +1.90%, compared to NVS's ROE of +0.25%. Regarding short-term risk, SCLXW is more volatile compared to NVS. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check NVS's competition here
AstraZeneca PLC (NYSE: AZN)
SCLXW vs AZN Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, AZN has a market cap of 289.1B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while AZN trades at $186.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AZN's P/E ratio is 20.13. In terms of profitability, SCLXW's ROE is +1.90%, compared to AZN's ROE of +0.22%. Regarding short-term risk, SCLXW is more volatile compared to AZN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check AZN's competition here
Amgen Inc. (NASDAQ: AMGN)
SCLXW vs AMGN Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, AMGN has a market cap of 248.8B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while AMGN trades at $460.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AMGN's P/E ratio is 20.57. In terms of profitability, SCLXW's ROE is +1.90%, compared to AMGN's ROE of +0.86%. Regarding short-term risk, SCLXW is more volatile compared to AMGN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check AMGN's competition here
Gilead Sciences, Inc. (NASDAQ: GILD)
SCLXW vs GILD Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, GILD has a market cap of 206.9B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while GILD trades at $166.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GILD's P/E ratio is -427.74. In terms of profitability, SCLXW's ROE is +1.90%, compared to GILD's ROE of -0.22%. Regarding short-term risk, SCLXW is more volatile compared to GILD. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check GILD's competition here
Novo Nordisk A/S (NYSE: NVO)
SCLXW vs NVO Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, NVO has a market cap of 177.7B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while NVO trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas NVO's P/E ratio is 10.03. In terms of profitability, SCLXW's ROE is +1.90%, compared to NVO's ROE of +0.54%. Regarding short-term risk, SCLXW is more volatile compared to NVO. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check NVO's competition here
Pfizer Inc. (NYSE: PFE)
SCLXW vs PFE Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, PFE has a market cap of 167.5B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while PFE trades at $29.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas PFE's P/E ratio is 9.63. In terms of profitability, SCLXW's ROE is +1.90%, compared to PFE's ROE of +0.05%. Regarding short-term risk, SCLXW is more volatile compared to PFE. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check PFE's competition here
Bristol-Myers Squibb Company (NYSE: BMY)
SCLXW vs BMY Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, BMY has a market cap of 127.1B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while BMY trades at $62.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BMY's P/E ratio is 10.48. In terms of profitability, SCLXW's ROE is +1.90%, compared to BMY's ROE of +0.44%. Regarding short-term risk, SCLXW is more volatile compared to BMY. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check BMY's competition here
Sanofi (NASDAQ: SNY)
SCLXW vs SNY Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, SNY has a market cap of 113.7B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while SNY trades at $47.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SNY's P/E ratio is 10.24. In terms of profitability, SCLXW's ROE is +1.90%, compared to SNY's ROE of +0.06%. Regarding short-term risk, SCLXW is more volatile compared to SNY. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check SNY's competition here
GSK plc (NYSE: GSK)
SCLXW vs GSK Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, GSK has a market cap of 101.8B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while GSK trades at $50.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GSK's P/E ratio is 10.87. In terms of profitability, SCLXW's ROE is +1.90%, compared to GSK's ROE of +0.23%. Regarding short-term risk, SCLXW is more volatile compared to GSK. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check GSK's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
SCLXW vs CELG-RI Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, CELG-RI has a market cap of 94.8B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while CELG-RI trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, SCLXW's ROE is +1.90%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, SCLXW is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check CELG-RI's competition here
Biogen Inc. (NASDAQ: BIIB)
SCLXW vs BIIB Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, BIIB has a market cap of 36.7B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while BIIB trades at $248.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BIIB's P/E ratio is 15.69. In terms of profitability, SCLXW's ROE is +1.90%, compared to BIIB's ROE of +0.02%. Regarding short-term risk, SCLXW is more volatile compared to BIIB. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check BIIB's competition here
Horizon Therapeutics Public Limited Company (NASDAQ: HZNP)
SCLXW vs HZNP Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, HZNP has a market cap of 26.6B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while HZNP trades at $116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas HZNP's P/E ratio is 61.86. In terms of profitability, SCLXW's ROE is +1.90%, compared to HZNP's ROE of +0.11%. Regarding short-term risk, SCLXW is more volatile compared to HZNP. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check HZNP's competition here
Grifols, S.A. (NASDAQ: GRFS)
SCLXW vs GRFS Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, GRFS has a market cap of 7.1B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while GRFS trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GRFS's P/E ratio is 9.69. In terms of profitability, SCLXW's ROE is +1.90%, compared to GRFS's ROE of +0.09%. Regarding short-term risk, SCLXW is more volatile compared to GRFS. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check GRFS's competition here
Organon & Co. (NYSE: OGN)
SCLXW vs OGN Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, OGN has a market cap of 3.6B. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while OGN trades at $13.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas OGN's P/E ratio is 4.13. In terms of profitability, SCLXW's ROE is +1.90%, compared to OGN's ROE of +0.22%. Regarding short-term risk, SCLXW is more volatile compared to OGN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check OGN's competition here
Amarin Corporation plc (NASDAQ: AMRN)
SCLXW vs AMRN Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, AMRN has a market cap of 241.1M. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while AMRN trades at $11.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AMRN's P/E ratio is -116.55. In terms of profitability, SCLXW's ROE is +1.90%, compared to AMRN's ROE of -0.04%. Regarding short-term risk, SCLXW is more volatile compared to AMRN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check AMRN's competition here
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA)
SCLXW vs MIRA Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, MIRA has a market cap of 23.3M. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while MIRA trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas MIRA's P/E ratio is -0.38. In terms of profitability, SCLXW's ROE is +1.90%, compared to MIRA's ROE of -1.07%. Regarding short-term risk, SCLXW is more volatile compared to MIRA. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check MIRA's competition here
Scilex Holding Company (NASDAQ: SCLX)
SCLXW vs SCLX Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, SCLX has a market cap of 11.7M. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while SCLX trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SCLX's P/E ratio is -0.04. In terms of profitability, SCLXW's ROE is +1.90%, compared to SCLX's ROE of +1.90%. Regarding short-term risk, SCLXW is more volatile compared to SCLX. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check SCLX's competition here
BioDelivery Sciences Intl, Inc. Wrrt (NASDAQ: BDSIW)
SCLXW vs BDSIW Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, BDSIW has a market cap of 0. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while BDSIW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BDSIW's P/E ratio is -0.43. In terms of profitability, SCLXW's ROE is +1.90%, compared to BDSIW's ROE of +0.57%. Regarding short-term risk, SCLXW is more volatile compared to BDSIW. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check BDSIW's competition here
Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT)
SCLXW vs CRXT Comparison November 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 7.6M. In comparison, CRXT has a market cap of 0. Regarding current trading prices, SCLXW is priced at $0.03 on the NASDAQ, while CRXT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CRXT's P/E ratio is -0.02. In terms of profitability, SCLXW's ROE is +1.90%, compared to CRXT's ROE of -4.63%. Regarding short-term risk, SCLXW is more volatile compared to CRXT. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check CRXT's competition here